Atkins patent opposition analysis

The comprehensive analysis of Atkins opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Atkins

Patent NumberTitleApplicantOpposition DateOpposition Company
Injectable Long-Acting Naltrexone Microparticle CompositionsPURDUE RESEARCH FOUNDATIONNov 6, 2024ALKERMES PHARMA IRELAND
Risperidone Sustained Release Microsphere CompositionSHAN DONG LUYE PHARMACEUTICALJul 7, 2021ALKERMES PHARMA IRELAND
Complexes Of Sirolimus And Its Derivatives, Process For The Preparation Thereof And Pharmaceutical Compositions Containing ThemNANGENEXNov 11, 2020ALKERMES PHARMA IRELAND
Risperidone Sustained Release Microsphere CompositionNANJING LUYE PHARMACEUTICALApr 17, 2020ALKERMES PHARMA IRELAND

Top companies who are the clients of Atkins